Our results demonstrated that downregulation of renal mitochondria PRR via PRR shRNA delivery efficiently blocked hyperglycemia-induced dysfunction of mitochondria by reversing SOD2 levels, inhibiting UCP2 protein levels, and increasing ATP synthesis. The gene discussed is UCP2; the disease is Hyperglycemia.